Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 550,381
  • Shares Outstanding, K 37,620
  • Annual Sales, $ 270,630 K
  • Annual Income, $ 61,340 K
  • 60-Month Beta 0.71
  • Price/Sales 1.57
  • Price/Cash Flow 9.72
  • Price/Book 0.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 11/30/19
See More
  • Average Estimate 0.01
  • Number of Estimates 2
  • High Estimate 0.02
  • Low Estimate 0.01
  • Prior Year 0.22
  • Growth Rate Est. (year over year) -95.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.72 +6.63%
on 10/04/19
19.59 -25.32%
on 09/23/19
-3.91 (-21.09%)
since 09/18/19
3-Month
13.72 +6.63%
on 10/04/19
21.90 -33.20%
on 07/19/19
-6.90 (-32.05%)
since 07/18/19
52-Week
13.72 +6.63%
on 10/04/19
25.48 -42.58%
on 04/01/19
-5.96 (-28.95%)
since 10/18/18

Most Recent Stories

More News
AngioDynamics Boosts VIT Product Portfolio With New Buyout

AngioDynamics (ANGO) is likely to see an expansion of its already existing VIT product portfolio with the buyout of Eximo Medical.

ABMD : 175.30 (-0.69%)
ANGO : 14.63 (-2.53%)
ARAY : 2.66 (+3.91%)
AVNS : 40.56 (+2.84%)
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Insulet Corp (PODD , HOLX , ANGO , ZBH , WMGI )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ANGO : 14.63 (-2.53%)
HOLX : 49.92 (+1.17%)
PODD : 153.74 (-1.75%)
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund

Accelmed, a group of funds investing in healthtech companies in the fields of medical device and digital health, announced today that it is establishing Accelmed Ventures II, a new venture capital fund...

ANGO : 14.63 (-2.53%)
CRY : 23.68 (-1.62%)
AngioDynamics (ANGO) Q1 Earnings Top, Revenues Lag Estimates

AngioDynamics (ANGO) keeps fiscal 2020 revenue guidance intact, slashes EPS view.

VAR : 114.62 (+0.44%)
ANGO : 14.63 (-2.53%)
SYK : 215.32 (-0.11%)
XRAY : 54.90 (-0.09%)
Luminex Gets FDA Nod for ARIES MRSA Assay, Boosts Platform

Luminex (LMNX) receives FDA clearance for the ARIES MRSA assay, which is likely to provide a boost to the company's ARIES platform.

ARAY : 2.66 (+3.91%)
ABMD : 175.30 (-0.69%)
ANGO : 14.63 (-2.53%)
LMNX : 20.03 (-0.72%)
AngioDynamics (ANGO) Q1 Earnings Beat Estimates

AngioDynamics (ANGO) delivered earnings and revenue surprises of 100.00% and -2.32%, respectively, for the quarter ended August 2019. Do the numbers hold clues to what lies ahead for the stock?

ANGO : 14.63 (-2.53%)
AngioDynamics Reports Fiscal 2020 First Quarter Financial Results

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results...

ANGO : 14.63 (-2.53%)
AngioDynamics Acquires Eximo Medical, Ltd. and its Innovative 355nm Laser Atherectomy Technology

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has acquired...

ANGO : 14.63 (-2.53%)
4.9% Return Seen to Date on SmarTrend Angiodynamics In Call (ANGO)

SmarTrend identified a Downtrend for Angiodynamics In (NASDAQ:ANGO) on August 13th, 2019 at $19.37. In approximately 2 months, Angiodynamics In has returned 4.90% as of today's recent price of $18.42....

ANGO : 14.63 (-2.53%)
Earnings Preview: AngioDynamics (ANGO) Q1 Earnings Expected to Decline

AngioDynamics (ANGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ANGO : 14.63 (-2.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

See More Share

Trade ANGO with:

Business Summary

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad...

See More

Key Turning Points

2nd Resistance Point 15.14
1st Resistance Point 14.89
Last Price 14.63
1st Support Level 14.46
2nd Support Level 14.29

See More

52-Week High 25.48
Fibonacci 61.8% 20.99
Fibonacci 50% 19.60
Fibonacci 38.2% 18.21
Last Price 14.63
52-Week Low 13.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar